News history January 08, 2024

Day	1 \| 2 \| 3 \| 4 \| 5 \| 6 \| 7 \| 8 \| 9 \| 10 \| 11 \| 12 \| 13 \| 14 \| 15 \| 16 \| 17 \| 18 \| 19 \| 20 \| 21 \| 22 \| 23 \| 24 \| 25 \| 26 \| 27 \| 28 \| 29 \| 30 \| 31
Months	January \| February \| March \| April \| May \| June \| July \|
Year	2024 \| 2023 \| 2022 \| 2021 \| 2020 \| 2019 \| 2018 \| 2017 \| 2016 \| 2015 \| 2014 \| 2013 \| 2012 \| 2011 \| 2010 \| 2009 \| 2008

Our articles published on 08/01/2024 .

Global markets live: Boeing, GSK, Hays, Shell, Eli Lilly...

January 09, 2024 at 04:50 pm

Behind the numbers - 180%, that's what Bitcoin gained since January 2023

January 09, 2024 at 04:12 pm

Gotham City sets its sights on Grifols

January 09, 2024 at 03:09 pm

Microchip sinks STMicroelectronics

January 09, 2024 at 03:08 pm

Nvidia comes to Wall Street's rescue

January 09, 2024 at 02:18 pm

ANALYST RECOMMENDATIONS : Blackrock, Blackstone, Exxon Mobil, Netflix, Charles Schwab...

January 09, 2024 at 10:20 am

UK shares struggle for direction after Wall Street rally

January 09, 2024 at 09:50 am

All the latest stock market news at 08/01/2024 .

3087 news

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alignment Healthcare, Inc. Announces Executive Appointments	13:00:00 09/01/2024 GMT
DOCOMO PACIFIC Deploys New 10G FTTP Service with Harmonic	13:00:00 09/01/2024 GMT
Hycroft Mining Holding Corporation Announces Additional Drill Results from Phase 2 of the 2022-2023 Exploration Drill Program At the Hycroft Mine	13:00:00 09/01/2024 GMT
Corbus Pharmaceuticals Holdings, Inc. Announces FDA Clearance of IND Application for its Anti-avb8 Monoclonal Antibody (CRB-601)	13:00:00 09/01/2024 GMT
Revvity, Inc. Provides Revenue Guidance for the Fourth Quarter 2023	13:00:00 09/01/2024 GMT
NGM Bio Announces New Clinical Data from Ongoing Trial of Ngm707 in Advanced Solid Tumors and Outlines Evolved Strategy for Aldafermin and Ngm120 to Focus on Rare Conditions with Significant Unmet Need	13:00:00 09/01/2024 GMT
Summit Materials, Inc. Appoints Marshall Moore as EVP, Chief Operations Officer	13:00:00 09/01/2024 GMT
Red Violet Announces Appointment of Bill Livek to Board of Directors	13:00:00 09/01/2024 GMT
Saudi Arabia tries to thread the needle between crude output, prices: Russell	13:00:00 09/01/2024 GMT
Wind overtakes coal for electricity generation in Europe: Maguire	13:00:00 09/01/2024 GMT
SAP Creates New Board Area Focused on Innovation Adoption in the Cloud	12:59:06 09/01/2024 GMT
Applied Materials, Google to Collaborate on AR Technology	12:58:06 09/01/2024 GMT
Lantheus Holdings, Inc. Provides Revenue Guidance for Its Fiscal Year Ended December 31, 2023	12:58:00 09/01/2024 GMT
HASI Announces Add-On Private Offering of $100 Million Green Senior Unsecured Notes	12:57:02 09/01/2024 GMT
EMP METALS REPORTS PRELIMINARY ECONOMIC ASSESSMENT ON VIEWFIELD LITHIUM BRINE PROJECT WITH PRE-TAX NPV OF US$1.49B, IRR OF 55% AND PAYBACK OF 2.1 YEARS	12:56:31 09/01/2024 GMT
Bayer starts Phase II study NIRVANA to evaluate elinzanetant in women with sleep disturbances associated with menopause	12:56:31 09/01/2024 GMT
Biotech companies to increase R&D spend but highlight complexity of clinical trials, ICON	12:56:30 09/01/2024 GMT
Allurion Announces Preliminary Fourth Quarter and Full Year2023 Results and Provides 2024 Outlook	12:56:28 09/01/2024 GMT
Bayer's elinzanetant meets all primary and key secondary endpoints in pivotal OASIS 1 and 2 Phase III studies	12:56:28 09/01/2024 GMT
Xponential Fitness, Inc. Provides 2023 Operating Highlights	12:56:27 09/01/2024 GMT
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(4)	12:56:27 09/01/2024 GMT
Seluxit again secured funding from the European Innovation Council to exhibit at the Mobile World Congress in Barcelona	12:56:27 09/01/2024 GMT
Seres Therapeutics Shares Rise 15% After Getting FDA Fast-Track Designation for Infection Treatment	12:56:07 09/01/2024 GMT
Lantheus Reports Preliminary Fiscal Year 2023 Revenue	12:56:02 09/01/2024 GMT
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results	12:56:02 09/01/2024 GMT
Bell Copper Corporation Provides Drilling Update from Big Sandy Porphyry Copper Project	12:56:00 09/01/2024 GMT
Bausch + Lomb Receives FDA Approval for TENEO Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction Surgery	12:55:55 09/01/2024 GMT
UCB announces European Commission approval of RYSTIGGO for the treatment of adults with generalized myasthenia gravis in Europe	12:55:55 09/01/2024 GMT
Novartis Scemblix shows superior major molecular response rates vs. standard of care TKIs in Phase III trial for newly diagnosed patients with chronic myeloid leukemia	12:55:55 09/01/2024 GMT
WuXi Biologics to Increase Manufacturing Capacity in Massachusetts	12:55:54 09/01/2024 GMT
Precigen Highlights Pipeline Updates to be presented at the 42nd Annual J.P. Morgan Healthcare Conference	12:55:54 09/01/2024 GMT
Pasithea Therapeutics Announces Invention of Crystalline Form of PAS-004, Establishes Strengthened Intellectual Property Position	12:55:54 09/01/2024 GMT
Nuvalent Announces 'OnTarget 2026' Operating Plan and Key Anticipated Milestones	12:55:54 09/01/2024 GMT
Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo in Multiple Countries	12:55:53 09/01/2024 GMT
Inotrem successfully reaches agreement with the FDA for a Phase 3 registration trial for nangibotide in septic shock	12:55:53 09/01/2024 GMT
HARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2023 NET PRODUCT REVENUE INCREASES MORE THAN 30 PERCENT, PROVIDES 2024 NET PRODUCT REVENUE GUIDANCE	12:55:52 09/01/2024 GMT
Haystack Oncology and Alliance Foundation Trials collaborate to use Haystack MRD technology in phase II clinical trial for unresectable stage III NSCLC	12:55:52 09/01/2024 GMT
U.S. District Court Issues Decision on REGENXBIO and University of Pennsylvania NAV Technology Patent Infringement Lawsuit	12:55:52 09/01/2024 GMT
Ensysce Biosciences Issues 2024 Shareholder Letter	12:55:51 09/01/2024 GMT
Rigel Pharmaceuticals Provides Business Update	12:55:51 09/01/2024 GMT
Biosion's Partner OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992	12:55:51 09/01/2024 GMT
LONGBOARD PHARMACEUTICALS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK AND FULL EXERCISE OF UNDERWRITERS OPTION TO PURCHASE ADDITIONAL SHARES	12:55:50 09/01/2024 GMT
Guardant Health Announces Preliminary Fourth Quarterand Full Year 2023 Results	12:55:50 09/01/2024 GMT
Biohaven Highlights Progress across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference	12:55:50 09/01/2024 GMT
PALATIN PROVIDES CORPORATE UPDATE AND HIGHLIGHTS STRATEGIC PRIORITIES FOR CALENDAR YEAR 2024	12:55:50 09/01/2024 GMT
AbbVie - Lutikizumab Showed Positive Results in a Phase 2 Trial of Adults with Moderate to Severe Hidradenitis Suppurativa as Program Advances to Phase 3	12:55:49 09/01/2024 GMT
Biomea Fusion Announces Dosing of First Type 1 Diabetes Patient in Phase II Study with BMF-219	12:55:49 09/01/2024 GMT
Pulmatrix Announces Stopping the PUR1900 Phase 2B Study Patient Enrollment and Closing the Study, in Agreement With Partner Cipla, to Preserve Cash and Facilitate Pursuit of Strategic Alternatives	12:55:49 09/01/2024 GMT
FDA Grants Soligenix 'Fast Track' Designation for Dusquetide in the Treatment of Oral Lesions of Behcet's Disease	12:55:49 09/01/2024 GMT
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results	12:55:48 09/01/2024 GMT
Lantheus Reports Preliminary Fiscal Year 2023 Revenue	12:55:48 09/01/2024 GMT
UK's Rwanda asylum legislation to return to parliament next week	12:55:14 09/01/2024 GMT
Rok Resources Announces Preliminary Economic Assessment Results for the Viewfield Lithium Brine Project	12:55:00 09/01/2024 GMT
Vericel Corporation Provides Earnings Guidance for the Fourth Quarter and Full-Year 2023	12:55:00 09/01/2024 GMT
Medexus Pharmaceuticals - Health Canada Accepts for Review Medexus's New Drug Submission for Topical Terbinafine	12:54:15 09/01/2024 GMT
AFFIMED ANNOUNCES LEADERSHIP CHANGE AND ORGANIZATIONAL RESTRUCTURING	12:54:15 09/01/2024 GMT
Microsoft's OpenAI Investment Could Face EU Probe	12:54:05 09/01/2024 GMT
Moderna Provides Business and Pipeline Updates at 42nd Annual J.P. Morgan Healthcare Conference	12:53:20 09/01/2024 GMT
Hemogenyx Pharmaceuticals plc - HEMO-CAR-T Process Qualification Run Completed	12:53:20 09/01/2024 GMT
DERMTECH ANNOUNCES POSITIVE TOPLINE RESULTS FROM TRUST 2 STUDY EVALUATING THE DERMTECH MELANOMA TEST	12:53:19 09/01/2024 GMT
Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma	12:53:19 09/01/2024 GMT
Aditxt, Inc.'s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.'s Proprietary Mitomic Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million	12:53:19 09/01/2024 GMT
Owlet Transforms Infant Care with the Launch of Two FDA-Cleared Devices, Dream Sock and BabySat	12:53:18 09/01/2024 GMT
Commerzbank AG: Announcement pursuant to Art. 5(1) lit. a) of Regulation (EU) No 596/2014 and Art. 2(1) of Delegated Regulation (EU) 2016/1052 / (Share Buyback Programme 2024)	12:50:01 09/01/2024 GMT
CanAlaska Uranium Ltd. Plans Aggressive 2024 Exploration Programs at West McArthur JV High-Grade Pike Zone	12:50:00 09/01/2024 GMT
Dollar tracks Treasury yields higher, bitcoin holds firm	12:49:38 09/01/2024 GMT
Delta Corp Limited Announces Address Change	12:49:00 09/01/2024 GMT
Delta Corp Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12:49:00 09/01/2024 GMT
ING: 10.5 million shares bought back last week	12:48:06 09/01/2024 GMT
Spain to issue net 55 billion euros worth of bonds in 2024	12:47:04 09/01/2024 GMT
Scottie Resources Corp. Reports New Assays on its Scottie Gold Mine Project in British Columbia's Golden Triangle, Including New High-Grade Intercepts on its D Zone Target	12:47:00 09/01/2024 GMT
Alarum Estimates Record Revenue and All Time High Operating Cashflow for the Fourth Quarter of 2023	12:46:01 09/01/2024 GMT
CMS: Commerzbank AG: Announcement pursuant to Art. 5(1) lit. a) of Regulation (EU) No 596/2014 and Art. 2(1) of Delegated Regulation (EU) 2016/1052 / (Share Buyback Programme 2024)	12:46:01 09/01/2024 GMT
Alarum Estimates Record Revenue and All Time High Operating Cashflow for the Fourth Quarter of 2023	12:45:04 09/01/2024 GMT
Dundee Precious Metals Achieves 2023 Gold Production Guidance; Announces Timing of Q4/23 Financial Results	12:45:01 09/01/2024 GMT

No results for this search

18 19 20 21 22

News history January 08, 2024

Our articles published on 08/01/2024 .

Filters

Most Read News

All the latest stock market news at 08/01/2024 .